A computational model of neurodegeneration in Alzheimer’s disease

被引:0
|
作者
D. Jones
V. Lowe
J. Graff-Radford
H. Botha
L. Barnard
D. Wiepert
M. C. Murphy
M. Murray
M. Senjem
J. Gunter
H. Wiste
B. Boeve
D. Knopman
R. Petersen
C. Jack
机构
[1] Mayo Clinic,Department of Neurology
[2] Mayo Clinic,Department of Radiology
[3] Mayo Clinic,Department of Neuroscience
[4] Mayo Clinic,Department of Information Technology
[5] Mayo Clinic,Department of Health Sciences Research
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Disruption of mental functions in Alzheimer’s disease (AD) and related disorders is accompanied by selective degeneration of brain regions. These regions comprise large-scale ensembles of cells organized into systems for mental functioning, however the relationship between clinical symptoms of dementia, patterns of neurodegeneration, and functional systems is not clear. Here we present a model of the association between dementia symptoms and degenerative brain anatomy using F18-fluorodeoxyglucose PET and dimensionality reduction techniques in two cohorts of patients with AD. This reflected a simple information processing-based functional description of macroscale brain anatomy which we link to AD physiology, functional networks, and mental abilities. We further apply the model to normal aging and seven degenerative diseases of mental functions. We propose a global information processing model for mental functions that links neuroanatomy, cognitive neuroscience and clinical neurology.
引用
收藏
相关论文
共 50 条
  • [21] Oral frailty and neurodegeneration in Alzheimer's disease
    Dibello, Vittorio
    Lozupone, Madia
    Manfredini, Daniele
    Dibello, Antonio
    Zupo, Roberta
    Sardone, Rodolfo
    Daniele, Antonio
    Lobbezoo, Frank
    Panza, Francesco
    NEURAL REGENERATION RESEARCH, 2021, 16 (11) : 2149 - 2153
  • [22] Proteomic profiling and neurodegeneration in Alzheimer's disease
    Tsuji, T
    Shiozaki, A
    Kohno, R
    Yoshizato, K
    Shimohama, S
    NEUROCHEMICAL RESEARCH, 2002, 27 (10) : 1245 - 1253
  • [23] Neurodegeneration in Alzheimer's disease: A new biomarker
    不详
    NEUROSCIENTIST, 2023, 29 (05): : 514 - 514
  • [24] Alzheimer's Disease with Substantia Nigra Neurodegeneration
    Ono, D.
    Sekiya, H.
    Murray, M.
    Dickson, D.
    Koga, S.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (06): : 575 - 576
  • [25] Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease
    Jakaria, Md.
    Belaidi, Abdel Ali
    Bush, Ashley I.
    Ayton, Scott
    JOURNAL OF NEUROCHEMISTRY, 2021, 159 (05) : 804 - 825
  • [26] Molecular aspects of neurodegeneration in Alzheimer's disease
    Russo, C
    Venezia, V
    Salis, S
    Dolcini, V
    Schettini, G
    FUNCTIONAL NEUROLOGY, 2002, 17 (02) : 65 - 70
  • [27] Alzheimer's disease linking neurodegeneration with neurodevelopment
    Grilli, M
    Toninelli, GF
    Uberti, D
    Spano, P
    Memo, M
    FUNCTIONAL NEUROLOGY, 2003, 18 (03) : 145 - 148
  • [28] NEUROGENESIS AND NEURODEGENERATION: IMPLICATIONS FOR ALZHEIMER'S DISEASE
    Lazarov, O.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 224 - 225
  • [29] Isoaspartate formation and neurodegeneration in Alzheimer's disease
    Shimizu, T
    Watanabe, A
    Ogawara, M
    Mori, H
    Shirasawa, T
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 381 (02) : 225 - 234
  • [30] A computational model of Alzheimer's disease at the nano, micro, and macroscales
    Chamberland, Eleonore
    Moravveji, Seyedadel
    Doyon, Nicolas
    Duchesne, Simon
    FRONTIERS IN NEUROINFORMATICS, 2024, 18